Mohit Gupta, MD| Urologic Oncology, Urology | MedStar Health
Mohit Gupta

Mohit Gupta, MD
Provider is directly employed by MedStar Health

4.9 out of 5 (281 reviews)

Specialties: Urologic Oncology, Urology

Languages: English

About me

Mohit Gupta, MD, is an Associate Professor of Urology and the Director of Urologic Oncology at MedStar Georgetown University Hospital. As a urologic oncologist, Dr. Gupta specializes in the treatment of kidney, bladder, prostate, upper-tract, testicular, and adrenal cancers.  His priority is to ensure that every step of a patient’s treatment process – from the initial clinic visit to their surgery – is performed safely and effectively.

Dr. Gupta’s expertise stems from years of specialized surgical experience, including both open and minimally-invasive techniques. He has extensive training in the use of laparoscopic, endoscopic, and robotic-assisted surgery for complex urologic cancers. Incorporating cutting-edge robotic technology allows Dr. Gupta to enhance surgical precision and often shorten recovery times for his patients. For cases where robotic surgery is not feasible, Dr. Gupta is one of the few surgeons in the Washington, DC region whose skillset includes conventional open surgery techniques.

Dr. Gupta, who is certified by the American Board of Urology, earned his medical degree from Jefferson Medical College and completed both his internship and residency training in urology at the University of Florida. He further specialized his clinical skillset at The Johns Hopkins Hospital during a fellowship in urologic oncology, a prestigious two-year specialized training program in urologic cancers that is accredited by the Society of Urologic Oncology. Following his training, Dr. Gupta served as a surgeon and an Assistant Professor at NYU Langone Health in New York, NY prior to joining the team at Medstar Georgetown University Hospital in 2022.

With numerous professional and academic accolades to his name, Dr. Gupta has published over 40 peer-reviewed articles, including multiple publications that have helped shape official guidelines published by the American Urologic Association (AUA). His research has been published in respected journals, including the Journal of Urology and European Urology. He is an active member of the AUA, European Association of Urology, and Society of Urologic Oncology. He is also a frequent and highly-sought speaker at national conferences and academic meetings.

Outside of his busy practice, Dr. Gupta enjoys exploring the vibrant restaurant scene and cultural events of Washington, D.C. He also active at his local CrossFit gym and values spending time with his family and close friends.

Philosophy of Care

Peers and patients regard Dr. Gupta as a diligent, compassionate physician. “As a urologic oncologist, my job is to help guide patients through the diagnosis, treatment, and follow-up of their urologic cancers. My commitment to attention to detail extends to each aspect of patient care, aiming not only to treat the disease but also to guide patients through their cancer journey safely and effectively.”

“Each patient’s cancer is unique, and as a result, each patient’s treatment plan needs to be individually tailored, taking into account their quality of life and personal preferences. My role is to serve as partner during what can be one of the most difficult times in a patient’s life; by working together, we can determine the best treatment options to pursue for each patient. I understand that a cancer diagnosis can be overwhelming, and I am dedicated to ensuring that my patients receive not only top-notch medical care but also the support, understanding, and empowerment they need throughout their treatment.”

“At Georgetown, I am able to collaborate closely with medical and radiation oncologists as part of a multidisciplinary team at Lombardi Comprehensive Cancer Center, Washington, DC’s only National Cancer Institute-designated comprehensive cancer center. This collaborative approach ensures that each patient benefits from the collective expertise of a team, contributing to a tailored treatment plan.”

“Your health and confidence in your treatment journey remain at the forefront of my practice, and I am eager to guide you through a personalized and comprehensive approach to urologic cancer care.”

Click here to learn about clinical trials available through MedStar Health. NOTE: When filling out the form, please choose "Genito-urinary" under Oncology group to view trials that Dr. Gupta is associated with. 

Clinical areas of focus

  • Adrenal Neoplasm
  • Bladder Cancer
  • Elevated Psa
  • Hematuria
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Robotic Adrenalectomy
  • Robotic Surgery For Bladder Cancer
  • Robotic Surgery For Kidney Cancer
  • Robotic Surgery For Prostate Cancer
  • Testicular Cancer
  • Upper Tract Urothelial Cancer
Show More

Conditions and procedures

Conditions I treat

  • Adrenal Neoplasm
  • Bladder Cancer
  • Elevated Psa
  • Hematuria
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Upper Tract Urothelial Cancer
Show All Show Less

Procedures I perform

  • Cystectomy
  • Cystoscopy
  • Lymph Node Dissection
  • Nephrectomy
  • Nephroureterectomy
  • Orchiectomy
  • Partial Cystectomy
  • Partial Nephrectomy
  • Radical Nephrectomy
  • Radical Prostatectomy
  • Robotic Adrenalectomy
  • Robotic Surgery For Bladder Cancer
  • Robotic Surgery For Kidney Cancer
  • Robotic Surgery For Prostate Cancer
  • Transurethral Resection Of Bladder
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

13950 Brandywine Road
Brandywine, MD, 20613


Fax 301-782-2223

Get Directions

miles away

Fax 301-782-2223

3800 Reservoir Road Northwest
HealthCare Center 3rd Fl
Washington, DC, 20007


Fax 877-625-1478

Get Directions

miles away

Fax 877-625-1478

1133 21st Street Northwest
Building 2
Washington, DC, 20036

Get Directions

miles away


MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • Cigna Achieve Medicare (HMO C-SNP)
    • Aetna Traditional Choice (PPO)
    • Innovation Health: Indemnity
    • Priority Partners - Maryland Health Choice
    • Tricare East Select
    • Cigna True Choice Medicare (PPO)
    • United Medicare Advantage DSNP District of Columbia
    • Aetna Quality Point of Service (POS)
    • WellPoint Maryland
    • Cigna True Choice Plus Medicare (PPO)
    • MedStar Family Choice DC Healthy Families
    • United Nursing Home Plan (C-SNP
    • Aetna Signature Administrator PPO/TPA
    • CareFirst MedStar Select PPO
    • Innovation Health: Open Network Only Plus
    • Beech Street PPO
    • Aetna Select HMO/HealthFund/Health Network
    • D-SNP)
    • United Group Medicare Advantage Plans
    • United Optimum Choice
    • Cigna POS Open Access & Open Access Plus
    • Aetna HealthFund/Health Network Option OA
    • Traditional Medicare Fee for Service
    • CareFirst (NCA) Indemnity
    • Aetna Choice POS & Choice POS II
    • Cigna Preferred Medicare
    • Innovation Health: Open POS Plus
    • Kaiser Select-Added Choice
    • Medicaid - District of Columbia
    • Cigna TotalCare (HMO D-SNP)
    • Carefirst Blue Preferred PPO
    • United Choice
    • Federal Employee Program (Std/Basic PPO/Blue Focus)
    • I-SNP
    • United MD IPA Preferred (POS)
    • CareFirst MedStar PPO
    • Cigna POS/Network POS
    • Aetna HMO-Open Access/Select OA
    • Aetna Managed Choice Open Access (POS)
    • Veterans Affairs Community Care Network (VA CCN)
    • Virginia Premier
    • Cigna HMO & Network (HMO)
    • CareFirst Maryland Indemnity or PPO
    • HumanaChoice PPO
    • CareFirst Group Medicare Advantage prescription drug benefit (PPO)
    • Health Services for Children with Special Needs (HSCSN)
    • Carefirst BlueChoice Open Access
    • Aetna HMO
    • United Community Plan - Maryland Health Choice Program
    • Aetna Elect Choice/ Open Access (POS)
    • Kaiser Select
    • Cigna PPO and PPO Plus
    • Cigna Choice Fund PPO
    • United Navigate
    • United GEHA (for all other states) Compass Rose
    • Kaiser Permanente Signature-Added Choice
    • Cigna Network Open Access
    • Innovation Health: PPO
    • Aetna Managed Choice (POS)
    • Innovation Health: POS Plus
    • Innovation Health: Open POS II
    • HumanaChoice Honor’s plan PPO
    • WellPoint Maryland - Maryland Health Choice
    • Cigna Alliance Medicare (HMO) |
    • Innovation Health: HMO & EPO Plus
    • Kaiser HMO Plus and DHMO Plus Member
    • Tricare Reserve Select
    • Innovation Health: Network Only Plus
    • United Core Essential (HMO)
    • Employee Health Plan (EHP)
    • Cigna Indemnity
    • Kaiser Medicare Advantage Signature and Select
    • Aetna Medicare Advantage HMO & PPO Plans
    • Aetna Elect Choice/ EPO (Aetna Health Fund)
    • Tricare for Life East
    • Medicaid - Virginia
    • MedStar Family Choice DC Healthcare Alliance
    • CareFirst BC/BS Advantage Core/Enhanced
    • United Mamsi Life & Health
    • Uniformed Services Family Health Plan (USFHP)
    • Medicaid - Maryland
    • United Options (PPO) (includes Empire PPO)
    • United Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • HealthyBlue PPO
    • CareFirst Administrators
    • CareFirst NASCO
    • Carefirst BlueChoice Opt Out Open Access
    • Private Health Care Systems (PHCS) (PPO)
    • United Erickson Advantage Plans
    • Carefirst Healthy Blue (HMO/POS)
    • Maryland Point of Service Plan (MPOS)
    • Carefirst BlueChoice Opt Out Plus Open Access (POS)
    • Veterans Affairs Community Care Network
    • United AARP Medicare Complete
    • United Select HMO - EPO/NPP
    • United Golden Rule
    • Carefirst BlueChoice HMO
    • UnitedHealthcare Individual Exchange Plans
    • Carefirst EPO
    • United Student Resources
    • United Select Plus (POS)
    • Cigna HMO Open Access
    • CareFirst Blue Card Program (Out-of-area BCBS plans)
    • Tricare East Prime
    • Kaiser Flexible Choice
    • Aetna Student Health Insurance
    • Aetna Open HMO/Open HMO Option/Open EPO Plus
    • United MD IPA (HMO)
    • Aetna Open Choice (PPO)
    • United Choice Plus
    • Police and Fire Clinic
    • Kaiser Medicare Plus
    • Innovation Health: POS
    • Kaiser Signature
    • CareFirst Group Medicare Advantage
    • Cigna EPO
    • MedStar Family Choice - Maryland Health Choice
    • Coventry Health Care National Network PPO
    • First Health PPO
    • Coventry of Delaware HMO/PPO
    • Coventry Health Care of Virginia
    • Great-West Healthcare POS/CIGNA



Board Certification: American Board of Urology, Urology

Fellowship Program: Johns Hopkins Hospital (2019)

Residency Program: University of Florida College of Medicine (2017)

Internship Program: University of Florida College of Medicine (2013)

Medical School: Jefferson Medical College (2012)

News and publications

  1. K Teter, G Jacobowitz, C Rockman, N Dagher, M Gupta, and HL Pachter. Surgical Management of Recurrent and Extra-adrenal Pheochromocytomas Requiring Vascular Resection and Reconstruction. Annals of Vascular Surgery. 2022..
  2. B Foerster, M Abufaraj, SF Matin, M Azizi, M Gupta, WM Li, T Seisen, T Clinton, E Xylinas, CM Mir, D Schweitzer, A Mari, S Kimura, M Badini, R Mathieu, JH Ku, G Marcq, U Anele,
  3. M Grabbert, AK Czech, T Muilwijk, A Pycha, D D’Andrea, F Petros, PE Spiess , TJ Bivalacqua, WJ-Jeng Wu, M Rouprêt, LM Krabbe, K Hendricksen, S Egawa, A Briganti, M Moschini, V Graffeille, W Kassouf, R Autorino, A Heidenreich, P Chlosta, S Joniau, F Soria, P Pierorazio, and SF Shariat. Pretreatment Risk Stratification for Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma (UTUC): An International Collaborative Study. European Urology. 2021; 80(4):507-515. PubMed PMID: 34023164.
  4. PM Pierorazio, JG Cheaib, HD Patel, M Gupta, R Sharma, A Zhang, G Tema, and EB Bass. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy, and Retroperitoneal Lymph Node Dissection for the Management of Early-Stage Testicular Germ Cell Tumors: A Systematic Review. Journal of Urology. 2021; 205(2):370-382. PubMed PMID: 32915080.
  5. G Marcq, B Foerster, M Abufaraj, SF Matin, M Azizi, M Gupta, WM Li, T Seisen, T Clinton, E Xylinas, CM Mir, D Schweitzer, A Mari, S Kimura, M Badini, R Mathieu, JH Ku, G Marcq, U Anele, M Grabbert, AK Czech, T Muilwijk, A Pycha, D D’Andrea, F Petros, PE Spiess , TJ Bivalacqua, WJ-Jeng Wu, M Rouprêt, LM Krabbe, K Hendricksen, S Egawa, A Briganti, M Moschini, V Graffeille, R Autorino, A Heidenreich, P Chlosta, S Joniau, F Soria, P Pierorazio, SF Shariat, and W Kassouf. Novel Classification For Upper Tract Urothelial Carcinoma To Better Risk-Stratified Patients Eligible To Kidney Sparing Strategies: An International Collaborative Study. Eur Urol Focus. 2021;S2405(21). PubMed PMID: 33773965.
  6. ZR Schwen ZR, JL Liu, AT Gabrielson, HD Patel, M Gupta, SP Rowe, AS Herati, PM Pierorazio. Testicular Ultrasound Underestimates the Size of Small Testicular Masses: a Radiologic-Pathologic Correlation Study. World J Urol. 2021; 39(9):3399-3405. PubMed PMID: 33710425.
  7. M Gupta, JG Cheaib, HD Patel, R Sharma, A Zhang, EB Bass, and PM Pierorazio. Diagnosis and Management of Intratubular Germ Cell Neoplasia in Situ: A Systematic Review. Journal of Urology. 2020; 204(1):33-41. PubMed PMID: 31967523.
  8. B Foerster, M Abufaraj, F Petros, M Azizi, M Gupta, D Schweitzer, V Margulis, T Iwata, S Kimura, A Shabsigh, A Briganti, JH Ku, T Muilwijk, W Kassouf, S Matin, P Spiess, PM Pierorazio, K Hendricksen, and S Shariat. Efficacy of Preoperative Chemotherapy on Outcomes of High-risk Upper Tract Urothelial Carcinoma (UTUC). Journal of Urology. 2020; 203(6):1101-1108. PubMed PMID: 31898919.
  9. HD Patel, M Gupta, JG Cheaib, R Sharma, A Zhang, EB Bass, and PM Pierorazio. Testis-Sparing Surgery and Scrotal Violation for Testicular Masses Suspicious for Malignancy: A Systematic Review and Meta-Analysis. Urologic Oncology. 2020; 38(5):344-353. PubMed PMID: 32192891.
  10. HD Patel, M Ramos, M Gupta, JG Cheaib, R Sharma, A Zhang, EB Bass, and PM Pierorazio. Magnetic Resonance Imaging to Differentiate the Histology of Testicular Masses: A Systematic Review of Studies with Pathologic Confirmation. Urology. 2020; 135:4-10. PubMed PMID: 31585196.
  11. K Koo, F Faisal, N Gupta, A Meyer, HD Patel, PM Pierorazio, and B Matlaga. Recommendations for Opioid Prescribing after Endourological and Minimally Invasive Urological Surgery: An Expert Panel Consensus. Journal of Urology. 2020; 203(1):151-158. Collaborator, Promoting Opioid Stewardship in Endourology Work Group. PubMed PMID: 31464563.
  12. PM Pierorazio, JG Cheaib, G Tema, HD Patel, M Gupta, R Sharma, A Zhang, and EB Bass. Performance Characteristics of Clinical Staging Modalities in Early-Stage Testicular Germ Cell Tumors: A Systematic Review. Journal of Urology. 2020; 203(5):894-901. PubMed PMID: 31609176.
  13. GA Joice, G Tema, A Semerjian, M Gupta, M Bell, J Walker, M Kates, and TJ Bivalacqua. Evaluation of Incisional Negative Pressure Wound Therapy in the Prevention of Surgical Site Occurrences After Radical Cystectomy: A New Addition to Enhanced Recovery After Surgery Protocol. European Urology Focus. 2020; 6(4):698-703. PubMed PMID: 31704281.
  14. HD Patel, PE Nichols, ZT Su, M Gupta, JG Cheaib, ME Allaf, and PM Pierorazio. Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer. Urology. 2020; 135:76-81. PubMed PMID: 31536739.
  15. A Srivastava, HD Patel, M Gupta, GA Joice, ZR Schwen, R Alam, MA Gorin, MH Johnson, ME Allaf, and PM Pierorazio. The Incidence, Predictors, and Survival of Disappearing Small Renal Masses on Active Surveillance. Urologic Oncology. 2020; 38(2):42.e1-42.e6. PubMed PMID: 31704140.
  16. HD Patel, A Semerjian, M Gupta, CP Pavlovich, MH Johnson, MA Gorin, ME Allaf, and PM Pierorazio. Surgical Removal of Renal Tumors with Low Metastatic Potential based on Clinical Radiographic Size: A Systematic Review of the Literature. Urologic Oncology. 2019; 37(8):519-524. PubMed PMID: 31202730.
  17. M Gupta, N Milbar, F Pederzoli, M Chappidi, M Kates, and TJ Bivalacqua. Impact of Intravesical Therapy for Non-Muscle Invasive Bladder Cancer on the Accuracy of Urinary Cytology. World Journal of Urology. 2019; 37(10):2051-2058. PubMed PMID: 30671639.
  18. HD Patel, M Gupta, GA Joice, A Srivastava, R Alam, ME Allaf, and PE Pierorazio. Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States. European Urology Oncology. 2019; 2(4):343-348. PubMed PMID: 31277771.
  19. M Gupta, HD Patel, and PM Pierorazio. Active Surveillance of Small Renal Masses: A Safe Management Strategy for Select Patients. European Urology. 2018; 74(2):165-166. PubMed PMID: 29685642.
  20. M Gupta, R Alam, HD Patel, MH Johnson, P Chang, AA Wagner, JM McKiernan, ME Allaf, and PM Pierorazio. Use of Delayed Intervention for Small Renal Masses Initially Managed With Active Surveillance. Urologic Oncology. 2019; 37(1):18-25. PubMed PMID: 30446459.
  21. M Gupta, HD Patel, ZR Schwen, PT Tran, and AW Partin. Adjuvant Radiation with Androgen Deprivation Therapy for Men with Lymph Node Metastases Following Radical Prostatectomy: Identifying Men Who Benefit. British Journal of Urology International. 2019; 123(2):252-260. PubMed PMID: 29626845.
  22. M Gupta, M Kates, and TJ Bivalacqua. Immunotherapy in Non-Muscle Invasive Bladder Cancer: Current and Emerging Treatments. Current Opinion in Oncology. 2019; 31(3):183-187. PubMed PMID: 30893148.
  23. ZR Schwen, M Gupta, and PM Pierorazio. A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer. Advances in Urology. 2018. PubMed PMID: 29853869; PubMed Central PMCID: PMC5960558.
  24. HD Patel, M Gupta, JJ Tosoian, HB Carter, BJ Trock, AW Partin, and JI Epstein. Sub-typing the Risk of Intermediate-Risk Prostate Cancer For Active Surveillance Based on Adverse Pathology at Radical Prostatectomy. Journal of Urology. 2018; 200(5):1068-1074. PubMed PMID: 29673946.
  25. M Gupta, CJ VandenBussche, and TJ Bivalacqua. Urinary Cytology and the Paris System for Reporting Urinary Cytology: Implications for Urological Management. Cytopathology. 2018; 29(4):368-370. PubMed PMID: 29575439.
  26. RS Liao, M Gupta, Z Schwen, HD Patel, M Kates, MH Johnson, N Hahn, D McConkey, TJ Bivalacqua, and PM Pierorazio. Comparison of Pathologic Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma. Journal of Urology. 2018; 200:68-73. PubMed PMID: 29307680.
  27. CJ VandenBussche, DB Allison, M Gupta, DL Rosenthal. A 20 Year and 46,000 Specimen Journey to Paris Reveals the Influence of Reporting Systems and Peer Feedback on Pathologist Practice Patterns. Cancer Cytopathology, 2018; 126(6):381-389. PubMed PMID: 29757495.
  28. BJ Otto, RS Terry, FG Lutfi, J Syed, HC Hamann, M Gupta, and VG Bird. The Effect of Continued Aspirin Therapy in Patients Undergoing PCNL. Journal of Urology. 2018; 199(3):748-53. PubMed PMID: 29107032.
  29. AC Uzosike, HD Patel, R Alam, ZR Schwen, M Gupta, MA Gorin, MH Johnson, H Gausepohl, MF Riffon, BJ Trock, P Chang, AA Wagner, JM McKiernan, ME Allaf, and PM Pierorazio. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry. Journal of Urology. 2018; 199(3):641-8. PubMed PMID: 28951284.
  30. M Gupta and TJ Bivalacqua. Surveillance Strategies for Non-Muscle Invasive Bladder Cancer. Bladder Cancer: A Joint Société Internationale d'Urologie - International Consultation on Urologic Diseases Consultation Consultation. ICUD-EAU; 2017. PubMed PMID: 30684034.
  31. MJ Blute, M Gupta, and PL Crispen. Lymph Node Dissection for Small Renal Masses. Urol Clin N Am 2017; 44(2): 269–274. PubMed PMID: 28411918.
  32. M Gupta, MJ Blute, LM Su, and PL Crispen. Delayed Intervention of Small Renal Masses on Active Surveillance. J Kidney Cancer VHL 2017; 4(2):24–31. PubMed PMID: 28725541; PubMed Central PMCID: PMC5515897.
  33. M Gupta, J McCauley, A Farkas, A Gudeloglu, M Neuberger, L Yeung, J Vieweg, P Dahm. Clinical Practice Guidelines on Prostate Cancer: A Critical Appraisal. Journal of Urology. 2015; 193(4):1153-8. PubMed PMID: 25451831.
  34. M Gupta and LM Su. Current and Evolving Uses of Optical Coherence Tomography in the Genitourinary Tract. Current Urology Reports. 2014; 16(3):15-22. PubMed PMID: 25677236.
  35. M Hsu, M Gupta, LM Su, J Liao. Intraoperative Optical Imaging and Tissue Interrogation During Urologic Surgery. Current Opinion in Urology. 2014; 24:66-74. PubMed PMID: 24240512; PubMed Central PMCID: PMC4057050.
  36. M Gupta, A. Akhavan, M. Hall, M. Palese. Negative Pressure Pulmonary Edema After Laparoscopic Donor Nephrectomy. Journal of the Society of Laparoendoscopic Surgeons. 2012; 16(4):647-9. PubMed PMID: 23484579; PubMed Central PMCID: PMC3558907.
Reviews and Editorials
  1. M Gupta and GD Steinberg. Editorial Comment. Journal of Urology. 2020; 204(5):987-988. PubMed PMID: 32909863.
  2. M Gupta and CP Pavlovich. Re: Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial. European Urology. 2019; 75(5):876. PubMed PMID: 30826221.
  3. M Gupta and PM Pierorazio. Editorial Commentary re: High Response Rates to Neoadjuvant Chemotherapy in High Grade Upper Tract Urothelial Carcinoma. Urology. 2019; 129:151. PubMed PMID: 28188422.
  4. M Gupta and PM Pierorazio. Editorial Commentary re: Differences at Presentation and Treatment of Testicular Cancer in Hispanic Men: Institutional and National Hospital-Based Analysis. Urology. 2018; 112:103-111. PubMed PMID: 29198422.
Book Chapters
  1. R Terry, M Gupta, and LM Su. Complications of Robot-Assisted Radical Prostatectomy. Robotics in Genitourinary Surgery. 2nd Edition. 2018. Ed. Zug: Springer International Publishing.
  2.  Gupta and PL Crispen. Management of Adrenal Disorders. Choe’s Urology Oral Board Self-Assessment. 4th Edition. Ed. L Yeung. Columbus: Anadem, 2016.
  3. M Gupta and L Yeung. Renal Transplantation. Choe’s Urology Oral Board Self-Assessment. 4th Edition. Ed. L Yeung. Columbus: Anadem, 2016.
  4. M Gupta and LM Su. Optical Coherence Tomography for Prostate Cancer and Beyond. Advances in Image-Guided Urologic Surgery. First Edition. Edited by Joseph Liao and Li-Ming Su, 2014; Springer, New York, NY.

Ratings and reviews

  • Explanations the care provider gave you about your problem or condition

  • Extent to which the care provider listened to you

  • Care provider’s discussion of any proposed treatment (options, risks, benefits, etc.)

  • Care provider’s efforts to include you in decisions about your care

  • Concern the care provider showed for your questions or worries

  • Likelihood of recommending this care provider to others

  • May 28, 2024

    I was exceptionally impressed with Dr Gupta and wish he had been my care provider from the outset ( I was there for a second opinion because I had been unable to meet with him in a timely manner after the referral and had to go elsewhere for my surgery)

  • May 7, 2024

    Dr. Gupta is the best!!

  • May 2, 2024

    Dr Gupta was amazing and he took his time to explain the whole process to me and I did not even have any questions at the end, that's how great he did. Thank you